663172-78-9 Usage
Uses
Used in Medicinal Chemistry:
Tert-butyl 6-hydroxy-3-azabicyclo[3.2.0]heptane-3-carboxylate is used as a molecular scaffold in medicinal chemistry for its potential to form the basis of new pharmaceutical compounds. Its unique structure allows for the development of innovative drugs with distinct properties and mechanisms of action.
Used in Organic Synthesis:
In the field of organic synthesis, tert-butyl 6-hydroxy-3-azabicyclo[3.2.0]heptane-3-carboxylate serves as a versatile intermediate or building block. Its functional groups and ring system enable the synthesis of a variety of complex organic molecules, contributing to the advancement of chemical research and the development of new materials.
Used in Research and Development:
Tert-butyl 6-hydroxy-3-azabicyclo[3.2.0]heptane-3-carboxylate is utilized in research and development as a subject of study for its unique structural features and potential applications. Researchers in various fields of chemistry explore its properties and reactivity to gain insights into new chemical reactions and the design of novel molecules.
Used in Chemical Education:
tert-butyl 6-hydroxy-3-azabicyclo[3.2.0]heptane-3-carboxylate can also be employed in chemical education as a teaching tool to illustrate the principles of organic chemistry, including the synthesis of complex molecules, the role of functional groups, and the impact of steric hindrance on molecular properties and reactivity.
Check Digit Verification of cas no
The CAS Registry Mumber 663172-78-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,6,3,1,7 and 2 respectively; the second part has 2 digits, 7 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 663172-78:
(8*6)+(7*6)+(6*3)+(5*1)+(4*7)+(3*2)+(2*7)+(1*8)=169
169 % 10 = 9
So 663172-78-9 is a valid CAS Registry Number.
InChI:InChI=1/C11H19NO3/c1-11(2,3)15-10(14)12-5-7-4-9(13)8(7)6-12/h7-9,13H,4-6H2,1-3H3
663172-78-9Relevant articles and documents
FXR (farnesol X receptor) agonist
-
Paragraph 0319; 0321; 0322; 0323, (2019/04/17)
The invention belongs to the technical field of medicine and particularly relates to a compound shown as formula (I) that is shown in the description, and its pharmaceutically acceptable salts, estersor stereoisomers, with R1, R2, R3, M1, M2, Q, L, ring A
TRICYCLIC GYRASE INHIBITORS
-
Paragraph 0141, (2015/03/28)
Disclosed herein are compounds having the structure of Formula I and pharmaceutically suitable salts, esters, and prodrugs thereof that are useful as antibacterially effective tricyclic gyrase inhibitors. Related pharmaceutical compositions, uses and methods of making the compounds are also contemplated.
Azabicyclic compounds are central nervous system active agents
-
Page 82, (2010/02/05)
Compounds of formula (I) are novel CNS active agents that are useful for treating pain and for treating other disorders associated with the cholinergic system.
